Oncolyze Announces FDA Orphan Drug Designation for OM-301 for the Treatment of Multiple Myeloma
Oncolyze, which already holds an Orphan Drug Designation for its lead drug candidate OM-301 in treating acute myeloid leukemia (AML), is pleased to announce that...
TNG Creative Wins Two Prestigious Awards for an Integrated Marketing Campaign
TNG Creative, an award-winning, healthcare-focused, boutique consultancy, today announced that it has been awarded the 2023 IAC Award for Best Biotechnology Integrated Ad Campaign for its work...